Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma

PURPOSE: Despite the high frequency of EGFR genetic alterations in glioblastoma (GBM), EGFR-targeted therapies have not had success in this disease. To improve the likelihood of efficacy, we targeted adult patients with recurrent GBM enriched for EGFR gene amplification, which occurs in approximatel...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JCO Precis Oncol
Main Authors: Chi, Andrew S., Cahill, Daniel P., Reardon, David A., Wen, Patrick Y., Mikkelsen, Tom, Peereboom, David M., Wong, Eric T., Gerstner, Elizabeth R., Dietrich, Jorg, Plotkin, Scott R., Norden, Andrew D., Lee, Eudocia Q., Nayak, Lakshmi, Tanaka, Shota, Wakimoto, Hiroaki, Lelic, Nina, Koerner, Mara V., Klofas, Lindsay K., Bertalan, Mia S., Arrillaga-Romany, Isabel C., Betensky, Rebecca A., Curry, William T., Borger, Darrel R., Balaj, Leonora, Kitchen, Robert R., Chakrabortty, Sudipto K., Valentino, Michael D., Skog, Johan, Breakefield, Xandra O., Iafrate, A. John, Batchelor, Tracy T.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2020
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446412/
https://ncbi.nlm.nih.gov/pubmed/32923886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00295
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki